Alembic Pharmaceuticals Limited

Web: alembic-india.com NSE: APLLTD BSE: 533573 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

797 15(-2%)

Volume

58k as on 22, Jul

Open

1,032

High

1,056

Low

1,038

812

VWAP

819

52 Week High

1,044

52 Week Low

636

Viand Research Rating

Quality Score

26/100

Growth Score

18/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

15,665

No. of Shares

19.7

P/E

27.36

P/B

4.22

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

15.44

ROCE

Profit Growth

Listing Date

20-Sep-11

Promoter Holding

69.74%

FII Holding

4.26%

DII Holding

16.17%

Price Chart

Price Performance

1 Week4%

1 Month4%

3 Months6%

6 Months6%

1 Year20%

YTD3%

Moving Average

5 Day SMA831

10 Day SMA831

20 Day SMA821

30 Day SMA798

50 Day SMA778

61 Day SMA777

80 Day SMA762

200 Day SMA805

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	853	837	848	852
Resistance 2	848	836	843	848
Resistance 1	841	835	840	840
Pivot Point	836	834	836	835
Support 1	828	832	831	827
Support 2	823	831	828	823
Support 3	816	830	823	815

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 69.74%	(0.01) 69.74%	(0.11) 69.74%	(0.01) 69.68%	(0.11) 69.67%	(0.01) 69.61%	(0.01) 69.61%	(0.01) 69.61%	(0.01) 69.61%	(0.01) 69.61%	(0.01) 69.61%	(0.01) 69.61%	(0.01) 69.61%	(0.01) 69.61%	(0.01) 69.61%	(0.01) 69.61%	(0.11) 69.61%	(0.01) 69.48%	(0.01) 69.48%
FIIs	(0.01) 4.26%	(0.21) 4.23%	(0.11) 4.04%	(0.01) 3.96%	(-0.21) 3.94%	(0.21) 4.17%	(-0.41) 3.94%	(-0.11) 4.32%	(-0.11) 4.46%	(0.01) 4.52%	(0.21) 4.51%	(-0.21) 4.34%	(-0.41) 4.55%	(-0.31) 4.99%	(-0.61) 5.32%	(-0.11) 5.94%	(0.11) 6.02%	(0.41) 5.89%	(0.01) 5.52%
DIIs	(0.01) 16.17%	(-0.11) 16.17%	(-0.21) 16.30%	(0.01) 16.46%	(0.41) 16.43%	(0.01) 16.05%	(0.61) 16.05%	(0.11) 15.47%	(0.91) 15.39%	(0.31) 14.51%	(0.61) 14.22%	(0.31) 13.65%	(0.61) 13.32%	(0.21) 12.76%	(0.41) 12.55%	(0.41) 12.15%	(0.11) 11.74%	(0.21) 11.61%	(0.01) 11.42%
Public	9.83%	9.84%	9.92%	9.91%	9.96%	10.17%	10.38%	10.61%	10.54%	11.36%	11.67%	12.39%	12.53%	12.64%	12.52%	12.30%	12.63%	13.03%	13.58%
No. of Shareholders	86,432	87,000	89,969	89,013	91,336	93,944	91,429	74,829	76,567	85,212	89,552	97,607	99,522	101,864	103,811	101,457	106,437	110,038	123,059

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	1848	1876	1910	1711	1770	1693	1648	1562	1517	1631	1595	1486	1406	1509	1475	1262	1416	1272	1292	1326
Sales Growth % (YoY)	4.4%	10.8%	15.9%	9.5%	16.7%	3.8%	3.3%	5.1%	7.9%	8%	8.1%	17.8%	-0.7%	18.7%	14.1%	-4.8%	10.6%	-3.2%	-11.3%	-1.1%
Sales Growth % (QoQ)	-1.5%	-1.8%	11.6%	-3.3%	4.5%	2.7%	5.5%	3%	-7%	2.3%	7.3%	5.7%	-6.8%	2.3%	16.9%	-10.9%	11.3%	-1.5%	-2.6%	-
Expenses	1620	1585	1594	1430	1498	1433	1409	1325	1257	1364	1387	1287	1203	1274	1244	1255	1268	1030	1054	1090
Operating Profit	228	292	316	281	271	260	239	237	260	266	208	199	204	235	231	7	148	242	239	236
OPM %	12	16	17	16	15	15	15	15	17	16	13	13	14	16	16	1	10	19	18	18
Other Income	2	-27	8	6	14	10	30	2	4	3	10	12	1	0	0	1	10	19	21	2
Interest	23	23	24	24	25	22	19	13	11	15	16	14	14	15	12	9	7	4	5	2
Depreciation	89	80	76	74	69	70	71	69	69	69	68	66	74	67	68	67	123	56	55	53
Profit before tax	119	162	224	190	192	178	180	157	183	185	135	130	116	154	151	-67	29	201	200	183
Tax %	-70	18	18	19	18	23	15	14	3	2	-1	7	-31	21	12	-2	24	14	20	19
Net Profit	202	132	184	154	157	138	153	135	178	180	137	121	153	122	133	-66	22	172	164	158
Net Profit Growth % (QoQ)	53%	-28.3%	19.5%	-1.9%	13.8%	-9.8%	13.3%	-24.2%	-1.1%	31.4%	13.2%	-20.9%	25.4%	-8.3%	301.5%	-400%	-87.2%	4.9%	3.8%	-
Net Profit Growth % (YoY)	28.7%	-4.3%	20.3%	14.1%	-11.8%	-23.3%	11.7%	11.6%	16.3%	47.5%	3%	283.3%	595.5%	-29.1%	-18.9%	-141.8%	-	-	-	-
TTM Net Profit	672	627	633	602	583	604	646	630	616	591	533	529	342	211	261	292	516	494	322	0
EPS in Rs	10.31	6.76	9.4	7.85	7.98	7.04	7.8	6.85	9.07	9.18	6.95	6.14	7.76	6.2	6.78	-3.35	1.12	8.74	8.34	8.37

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	7345	6672	6229	5653	5306	5393	4606	3935	3131	3105	3166	2056	1863	1520
Sales Growth %	10.1%	7.1%	10.2%	6.5%	-1.6%	17.1%	17.1%	25.7%	0.8%	-1.9%	54%	10.4%	22.6%	3.8%
Expenses	6226	5664	5296	4970	4432	3913	3383	3061	2488	2490	2159	1653	1506	1268
Operating Profit	1118	1008	932	682	874	1480	1223	874	643	615	1007	403	358	252
OPM %	15	15	15	12	16	27	27	22	21	20	32	20	19	17
Other Income	-12	56	28	-2	56	87	-39	9	7	2	7	4	4	4
Interest	94	79	56	50	18	16	27	18	3	5	5	4	10	15
Depreciation	319	279	273	275	287	183	157	115	105	83	72	44	40	35
Profit before tax	694	707	632	355	625	1368	1000	749	541	529	936	359	311	206
Tax %	3	18	3	4	17	19	20	21	22	23	23	21	24	20
Net Profit	671	582	616	342	521	1146	801	583	413	403	720	283	236	165
Net Profit Growth %	15.3%	-5.5%	80.1%	-34.4%	-54.5%	43.1%	37.4%	41.2%	2.5%	-44%	154.4%	19.9%	43%	-
EPS in Rs	34.33	29.68	31.33	17.4	26.5	58.33	43.97	31	21.89	21.39	38.2	15.01	12.49	8.77
Dividend Payout %	35	37	35	46	38	24	23	18	18	19	9	23	24	29

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	783	88	803	724	552	1463	449	812	312	329	948	172	240	265
Cash from Investing Activity	-506	-568	-321	-448	-372	-840	-731	-756	-884	-486	-307	-256	-81	-67
Cash from Financing Activity	-164	444	-438	-262	-217	-597	155	59	503	-129	-224	87	-151	-229
Net Cash Flow	113	-37	45	14	-37	26	-127	115	-69	-286	417	3	8	-31

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	39	39	39	39	39	39	39	39	38	38	38	38	38	38	38	38
Reserves	5636	5280	5152	4849	4779	4331	5198	5028	3182	2681	2182	1865	1560	847	638	465
Borrowings	1430	1489	1258	1066	513	722	717	584	1747	1128	708	89	114	264	109	187
Other Liabilities	1658	1589	1324	1276	1114	1090	1167	1058	1022	931	1013	698	718	493	432	358
Total Liabilities	8763	8397	7773	7230	6446	6183	7122	6709	5989	4778	3941	2689	2429	1641	1217	1048
Fixed Assets	3130	2834	2524	2463	2547	2398	1798	1788	1552	1158	993	799	708	547	397	344
CWIP	634	903	837	662	524	601	2304	2183	1846	1551	1010	396	93	83	21	32
Investments	141	129	127	102	93	96	118	236	18	49	42	50	87	2	3	3
Other Assets	4858	4531	4285	4004	3281	3087	2902	2502	2573	2019	1896	1444	1541	1009	796	668
Total Assets	8763	8397	7773	7230	6446	6183	7122	6709	5989	4778	3941	2689	2429	1641	1217	1048

Delivery

#	Date	707 21% 855	Value (Cr)	Q/T 56	Del 53	Del 24
1	22-Jul	812	5	13	57	3
2	21-Jul	834	4	10	50	2
3	20-Jul	843	7	10	54	4
4	17-Jul	825	6	11	50	3
5	16-Jul	840	8	11	44	3
6	15-Jul	850	18	12	48	8
7	14-Jul	821	10	11	29	3
8	13-Jul	831	8	9	46	4
9	10-Jul	837	9	11	53	5
10	9-Jul	817	5	9	46	2
11	8-Jul	811	12	12	43	5
12	7-Jul	829	7	12	43	3
13	6-Jul	836	19	20	66	12
14	3-Jul	824	12	15	34	4
15	2-Jul	818	9	14	33	3
16	1-Jul	829	20	15	33	7
17	30-Jun	823	74	38	65	48
18	29-Jun	787	11	11	41	5
19	25-Jun	772	2	9	51	1
20	24-Jun	781	3	14	40	1
21	23-Jun	777	4	8	44	2
22	22-Jun	781	17	17	33	6
23	19-Jun	763	21	19	20	4
24	18-Jun	750	4	11	38	2
25	17-Jun	746	3	12	44	1
26	16-Jun	746	4	16	55	2
27	15-Jun	738	4	14	49	2
28	12-Jun	743	6	12	20	1
29	11-Jun	735	23	19	40	9
30	10-Jun	737	17	20	69	11
31	9-Jun	732	17	17	74	13
32	8-Jun	746	34	17	48	16
33	5-Jun	738	7	11	29	2
34	4-Jun	738	47	104	91	42
35	3-Jun	724	5	11	46	2
36	2-Jun	726	3	9	42	1
37	1-Jun	720	6	12	49	3
38	29-May	736	10	13	55	6
39	27-May	754	4	12	48	2
40	26-May	760	10	29	71	7
41	25-May	762	7	18	64	4
42	22-May	756	15	15	43	6
43	21-May	749	7	24	67	5
44	20-May	752	5	10	45	2
45	19-May	751	17	14	27	4
46	18-May	724	24	14	34	8
47	15-May	784	30	14	15	4
48	14-May	786	13	13	22	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	15,665c	257c	1.61
22-Jul	15,922c	521c	3.17
21-Jul	16,443c	169c	1.04
17-Jul	16,274c	294c	1.77
16-Jul	16,567c	10c	0.06
15-Jul	16,577c	434c	2.69
14-Jul	16,143c	156c	0.96
13-Jul	16,299c	148c	0.90
10-Jul	16,447c	408c	2.54
09-Jul	16,040c	39c	0.25
08-Jul	16,000c	343c	2.10
07-Jul	16,343c	105c	0.64
06-Jul	16,448c	431c	2.69
02-Jul	16,018c	298c	1.83
01-Jul	16,316c	103c	0.64
30-Jun	16,213c	866c	5.64
29-Jun	15,347c	232c	1.53
26-Jun	15,115c	55c	0.36
25-Jun	15,170c	189c	1.23
24-Jun	15,359c	125c	0.82
23-Jun	15,234c	39c	0.26
22-Jun	15,273c	258c	1.71
19-Jun	15,016c	410c	2.81
17-Jun	14,606c	78c	0.53
16-Jun	14,683c	160c	1.10
15-Jun	14,523c	123c	0.84
12-Jun	14,646c	45c	0.31
11-Jun	14,601c	98c	0.67
10-Jun	14,699c	0	0

Stock Checklist

Price is below from 52 week high low average: 21%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 80 fund scheme(s) across 17 fund house(s) as of Jul26 · Total value ₹3,173 Cr · 13 increasing / 4 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
DSP Mutual Fund	26	1.24%	-	1103.2
Kotak Mahindra Mutual Fund	2	1.51%	+0.02%	564
ICICI Prudential Mutual Fund	8	1.92%	+0.63%	517.6
Edelweiss Mutual Fund	7	0.51%	-	452
Union Mutual Fund	2	1.22%	-	198.6
Axis Mutual Fund	4	0.20%	-	193.1
ICICI Prudential Asset Management Company Limited	1	0.45%	+0.45%	42.4
Motilal Oswal Mutual Fund	4	0.27%	-	24.5
Aditya Birla Sun Life Mutual Fund	2	1.35%	-	24.3
HDFC Mutual Fund	6	0.39%	+0.07%	22.1
UTI Mutual Fund	2	0.68%	-	15.5
Abakkus Mutual Fund	2	1.55%	-	14
Groww Mutual Fund	4	1.15%	-	1.5
Bandhan Mutual Fund	4	0.16%	-	0.1
Angel One Mutual Fund	2	0.02%	-	0
Mirae Asset Mutual Fund	2	0.02%	-	0
Taurus Mutual Fund	2	0.00%	-0.38%	0

Alembic Pharmaceuticals Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements